Feb 4 Boston Scientific Corp on Tuesday reported higher fourth-quarter earnings on stronger sales of its implantable devices that manage irregular heart rhythms.
The medical device maker said it had earned $108 million, or 8 cents a share, compared with $60 million, or 4 cents a share, a year earlier.
Excluding special items, earnings were 21 cents a share.
Sales rose 1 percent to $1.84 billion.
Boston Scientific's shares, which more than doubled last year on anticipation of a recovery in the heart rhythm device market and enthusiasm about the company's product pipeline, were up 1.8 percent at $13.25 in trading before the market opened.
Norway government aims to sign 2017 spending plan on Saturday -source
OSLO, Dec 3 Norway's right wing minority coalition expects to sign a deal with centrist partners in parliament on Saturday for a 2017 fiscal budget, which would rescue the government from collapse, a source close to the talks told Reuters.